Pharmafile Logo
Pharmafocus logo
Advanced Search
novartis_outside_1

Novartis migraine prevention drug scores EU approval

July 31, 2018
Manufacturing and Production, Sales and Marketing Aimovig, Europe, Novartis, migraine, pharma

Novartis is celebrating the news that its calcitonin gene-related peptide receptor (CGRP-R) pathway therapy Aimovig (erenumab) has been approved by …

News
Mandeville KL, Satherley R, Hall JA, et al Political views of doctors in the UK: a cross-sectional study J Epidemiol Community Health Published Online First: 30 July 2018. doi: 10.1136/jech-2018-210801

Study reveals doctors political views as BMA backs Brexit final say

July 31, 2018
Manufacturing and Production BMA, NHS, UK, brexit, doctors, politics

The London-based British Medical Association (BMA), which represents 156,000 doctors and 19,000 medical students, is supporting calls for a ‘final …

News

Progenics’ Azedra becomes first FDA-approved treatment for adrenal tumours

July 31, 2018
Manufacturing and Production, Sales and Marketing Cancer, FDA, Progenics, adrenal cancer, pharma

The FDA has approved its first-ever drug for rare, unresectable tumours of the adrenal gland with its decision to authorise …

News
Chittagong, Bangladesh in the rain

GSK announces closure of Bangladesh facilities

July 30, 2018
Manufacturing and Production Bangladesh, Chittagong, GSK, closure, manufacturing

The British multinational GlaxoSmithKline has announced the closure of its facilities in Bangladesh after more than six decades of operation …

News
wockhardt_hospital_mumbai

Wockhardt launches $40m manufacturing plant in Dubai

July 30, 2018
Manufacturing and Production, Sales and Marketing Antibiotics, Dubai, India, Wockhardt, antibiotic resistance, pharma

Indian pharmaceutical firm Wockhardt has launched its first manufacturing facility in Dubai’s Jebel Ali Free Zone (Jafza). Costing $40 million, …

News
Medicines in an automated pharmacy

EU Commission grants market authorisation for Sandoz’ Humira biosimilar

July 30, 2018
Sales and Marketing FDA, Sandoz, approval, biosimilar, european commision

The European Commission has granted marketing authorisation to Sandoz’ biosimilar Hyrimoz for use in all indications, including rheumatoid arthritis, plaque …

News
john-milligan-thumbnail-300x300

Gilead’s CEO and Chairman to both step down before year’s end

July 30, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, pharma

Gilead has announced that its President and Chief Executive Officer Dr John Milligan (pictured) will be stepping down by the …

Appointment

Living with Behçet’s disease

July 30, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Behçet's disease, patient experience, pharma

Suzanne Morris speaks to Pharmafocus to discuss her life with Behçet’s disease, a rare condition characterised by the inflammation of …

Feature
White blood cells

CHMP recommend white blood cell growth stimulator biosimilar to EMA

July 30, 2018
Sales and Marketing Amgen, CHMP, EMA, Neulasta, biosimilar, chemotherapy, pegfilgrastim

The European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of two separate …

News
shutterstock_38078521

Tonix plunges 68% after PTSD drug failure

July 30, 2018
Research and Development, Sales and Marketing PTSD, Tonmya, pharma, tonix

Tonix Pharmaceuticals has announced that it has terminated its Phase 3 study of Tonmya (cyclobenzaprine HCl sublingual tablets) in military-related …

News
British army soldier marching

Army to ferry medicines in case of no-deal Brexit

July 30, 2018
Sales and Marketing UK, army, brexit, medicines, pharma, politics, supply chains

Ministers have established plans to use the army to deliver medicines, food and fuel in the event of a no-deal …

News
sean-harper

Amgen announces resignation of two top executives

July 27, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, Anthony C Cooper, R&D, biotech, retire, sean harper

Amgen’s head of R&D, Dr Sean Harper, has announced that he is retiring from his current position as Executive Vice …

Appointment
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

July 27, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, China, GSK, Gilead, J&J, JJ, Pfizer, Remicade, Roche, antimicrobial resistance, biosimilar, pharma, pricing, viagra

With the UK in the grip of a record-breaking heatwave, it’s hard to focus on much else over here, but …

News
32514377531_3583dbc34b_z

Those at risk of HIV to be offered PrEP drugs in England and Northern Ireland

July 27, 2018
Medical Communications AIDS, England, HIV, PrEP, Terrence Higgins Trust

Those at risk of contracting HIV will now be offered PrEP drugs in England and Northern Ireland through a programme …

News
takeda_usa_pharmaceuticals_u

Takeda’s Alunbrig topples Pfizer’s Xalkori in ALK-positive lung cancer

July 27, 2018
Medical Communications, Research and Development Alunbrig, Cancer, NSCLC, Pfizer, Takeda, Xalkori, lung cancer, pharma

Takeda has unveiled new Phase 3 data showing that its tyrosine kinase inhibitor (TKI) Alunbrig (brigatinib) not only met its …

News
Canary Wharf European Medicines Agency

Landlord demands EMA pay £500m for Canary Wharf lease

July 27, 2018
Medical Communications Canary Wharf, EMA, Litigation, London, amsterdam, court

A British landlord is taking the European Medicines Agency (EMA) to court over a £500 million bill for unpaid rent. …

News
Scientist looking at medicinal cannabis in a laboratory

Cannabis-derived medicinal products to become available in UK

July 26, 2018
Medical Communications cannabis, law, medicinal marijuana, prescription, sajid javid, schedule drugs, uk politics

Home Secretary Sajid Javid has announced that cannabis derived medicinal products will be made available on prescription “by the autumn” …

News
gsk_boronia_australia

GSK forges $300m partnership with 23andMe to boost preclinical R&D

July 26, 2018
Research and Development 23andME, GSK, GlaxoSmithKline, collaboration, genetics, pharma

In a bid to supercharge its drug discovery efforts, GlaxoSmithKline has sealed a $300 million deal with personal genomics and …

News

Merck KGaA announces new Senior Vice President, Head of Global Affairs

July 26, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Dr Maria Rivas, Germany, Merck, Merck KGaA, research and development

Merck KGaA has announced the appointment of Dr Maria Rivas as Senior Vice President, Head of Global Affairs. Dr Rivas, …

Appointment

Gilead’s CEO and Chairman to both step down before year’s end

July 26, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, pharma

Gilead has announced that its President and Chief Executive Officer Dr John Milligan (pictured) will be stepping down by the …

News
The Gateway to Local Adoption Series

Latest content

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026

Rentschler Biopharma appoints Detra Glinatsis as Head of Business Development US

January 29, 2026

Five Facts about spinal muscular atrophy

January 28, 2026